Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2018 013 021.7 |
96 | EP file number | EAKZ | 18 70 9132.7 |
86 | WO file number | WAKZ | PCT/US2018/012633 |
97 | EP publication number | EPN | 3601533 |
87 | WO publication number | WPN | 2018182817 |
54 | Designation/title | TI | VORGÄNGE ZUR HERSTELLUNG VON TUMORINFILTRIERENDEN LYMPHOZYTEN UND DEREN VERWENDUNGEN IN DER IMMUNTHERAPIE |
51 | IPC main class | ICM (ICMV) | C12N 5/0783 (2010.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12M 1/04 (2006.01) |
22 | DE application date | DAT | Jan 5, 2018 |
96 | EP application date | EAT | Jan 5, 2018 |
86 | WO application date | WAT | Jan 5, 2018 |
43 | Date of first publication | OT | Oct 4, 2018 |
| Date of publication of grant | PET | Feb 24, 2021 |
71/73 | Applicant/owner | INH | Iovance Biotherapeutics, Inc., San Carlos, CA, US |
72 | Inventor | IN | WARDELL, Seth, Tampa, FL 33620, US; BENDER, James, Rancho Santa Margarita, CA 92688, US; LOTZE, Michael, T., Pittsburgh, PA 15232, US |
74 | Representative | VTR | Hernandez, Yorck, Dipl.-Ing., 82031 Grünwald, DE |
| Address for service | | HERNANDEZ IP, 82031 Grünwald, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762567121 P Oct 2, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762577655 P Oct 26, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762582874 P Nov 7, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762596374 P Dec 8, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762478506 P Mar 29, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762554538 P Sep 5, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762539410 P Jul 31, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762548306 P Aug 21, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762559374 P Sep 15, 2017
|
| Due date | FT FG | Jan 31, 2026 Annual fee for the 9th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003601533A1 Searchable text:
EP000003601533A1 Original document:
EP000003601533B1 Searchable text:
EP000003601533B1 Original document:
WO002018182817 Searchable text:
WO002018182817 |
43 | Date of first publication | EVT | Oct 4, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Feb 5, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 4, 2025 (Show all update days)(Hide all update days)- Feb 4, 2025
- Due date: changed
- Procedures: Procedure relating to PCT application, Publication of PCT application, 04.10.2018: deleted
- Feb 2, 2024; Jun 30, 2023; Feb 3, 2022; Jan 13, 2022; Dec 9, 2021; Jul 8, 2021; Apr 21, 2021; Mar 18, 2021; Feb 10, 2021; Feb 4, 2021
- Historical data not available for this/these date(s)
- Feb 5, 2020
- Date of the first transfer into DPMAregister
|